<p>Retatrutide is among a new class of weight loss drugs being tested for their effectiveness</p>
GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone, which is involved in regulating appetite and insulin secretion. These drugs are primarily used for the treatment of type 2 diabetes and obesity, as they help to reduce food intake and promote weight loss.
Clinical trials are research studies performed on human participants to evaluate the efficacy and safety of medical interventions, such as drugs or vaccines. They are essential for determining how well a treatment works and for identifying any potential side effects.